In a prospective evaluation using a [18F]fluorodeoxyglucose positron emission tomography (FDG-PET), Tateishi and coworkers observed that GLUT-1 expression and enhanced glucose metabolism were associated with tumour grade in bone and soft tissue sarcomas [39]. The gene discussed is SLC2A1; the disease is neoplasm.